A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?

2013 ◽  
Vol 67 ◽  
pp. 304-317 ◽  
Author(s):  
Frederick Rohan Walker
Drugs ◽  
2006 ◽  
Vol 66 (16) ◽  
pp. 2095-2107 ◽  
Author(s):  
Joost P van Melle ◽  
Peter de Jonge ◽  
Maarten P van den Berg ◽  
Harm J Pot ◽  
Dirk J van Veldhuisen

2001 ◽  
Vol 79 (1) ◽  
pp. 95-100 ◽  
Author(s):  
E M Cunha ◽  
J Machado

The selective serotonin reuptake inhibitors (SSRIs) fluoxetine (Nodep) and fluvoxamine (Dumyrox) are drugs commonly prescribed for the treatment of depression in humans. They act to increase serotonin (5-hydroxytryptamine) neurotransmission by inhibiting reuptake transport proteins at synapses. A similar effect of SSRIs seems to occur naturally in one group of invertebrates, the molluscs. In this study the action of these drugs at different concentrations and under different conditions was tested in the freshwater mussel Anodonta cygnea. Fluoxetine was more potent than fluvoxamine, inducing an intense release of larvae (parturition) at a concentration of 1 × 10–6 M in the presence of light. The non-SSRI antidepressants trazodone (Triticum), mianserine (Tolvon), and L-5-hydroxytryptophan (Cincofarm), which are known to have different serotoninergic mechanisms, had a strong, no, and a weak effect, respectively, on larval parturiton in A. cygnea. These effects suggest that serotonin could be a normal and relevant mediator of larval parturition in A. cygnea. Other parallel visible signs due to incubation with SSRIs were an increase in the volume of the foot and gills through water uptake and stimulation of valve movements. These results indicate that incubation with SSRIs is potentially important in culturing the larvae of freshwater bivalves, since it facilitates control of the intensity and timing of larval parturition.


2020 ◽  
Author(s):  
Nirmal Raj Marasine ◽  
Sabina Sankhi ◽  
Rajendra Lamichhane ◽  
Nim Bahadur Dangi

Abstract Introduction: Depression is an important global public health problem due to its relatively high lifetime prevalence and significant disability caused by it. It is associated with functional impairment and high morbidity and mortality. Antidepressant medication is considered to be the best treatment option for depressionMethod: Literature searches (2000-2019) were performed using PubMed, HINARI and Google Scholar that analyze the pattern of prescription of antidepressants among the patients of depression. .Results: Females suffered from depression more than their male counterparts. Married people, housewives, lower income people, employees and highly educated people suffered more from depression. Selective Serotonin Reuptake Inhibitors (SSRI) like Sertraline, was found out to be the most preferred antidepressant among the depressive patients. Conclusion: Our Study suggested that out of five major antidepressant drugs being available for the treatment of depression, selective serotonin reuptake inhibitors are preferred over others because of their better side effect and tolerability profile.


2000 ◽  
Vol 12 (S1) ◽  
pp. 245-251 ◽  
Author(s):  
David L. Sultzer

Depression, psychosis, agitation, and aggression are fundamental clinical aspects of Alzheimer's disease (AD) and other dementia syndromes. Although behavioral, environmental, and pharmacologic interventions often help ameliorate these symptoms, the efficacy of specific interventions is uncertain, and adverse effects of medications are common.


Sign in / Sign up

Export Citation Format

Share Document